跳至主要内容
临床试验/NCT00622531
NCT00622531终止不适用

Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)

Siemens Healthcare Diagnostics Inc11 个研究点 分布在 2 个国家目标入组 108 人开始时间: 2007年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
108
试验地点
11
主要终点
composite endpoint of all cause mortality, hospitalization due to worsening heart failure and administration of IV drug therapy for worsening heart failure.

研究概览

简要总结

The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible subjects must be diagnosed with heart failure and have an abnormal BNP reading.

排除标准

  • 未提供

结局指标

主要结局

composite endpoint of all cause mortality, hospitalization due to worsening heart failure and administration of IV drug therapy for worsening heart failure.

时间窗: 12 months

次要结局

  • Quality of life assessments of two treatment groups(12 months)
  • change in therapy based on BNP usage(12 months)
  • NYHA classifications in the two treatment groups(12 months)
  • number of serious adverse events for the two groups(12 months)

研究者

发起方
Siemens Healthcare Diagnostics Inc
申办方类型
Industry
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验